The results show that the use of DPP4 inhibitors and the history of cerebrovascular accident were significantly associated with an increased risk of thrombotic events or acute arterial embolism (p = 0.023 and p = 0.031, respectively). The gene discussed is DPP4; the disease is Stroke.